Gao Fu, director of the Chinese Center for Disease Control and Prevention, admitted on Monday “She is not very tall” Efficacy of topical drugs Coronavirus. Therefore, he reported that they are analyzing a mixed vaccine against COVID to improve its ability to fight the disease.
What did Chinese officials say about the mixed COVID vaccine?
The director of the Chinese Center for Disease Control and Prevention said that the Chinese government is studying a mixed COVID vaccine. Or change the vaccination guidelines to improve the effectiveness of drugs against coronavirus.
Yes, according to country, The efficacy of the vaccine they developed in China is between 50% and 79%, which is lower than Pfizer’s 95% and Moderna’s 94%, Although those in Asian countries do not need strict cold conditions.
China evaluates two ways to improve vaccination
According to the press conference of the South China Morning Post, Gao Fu pointed out that the Chinese government is considering two ways to improve to solve the problem of low efficacy of local vaccines: Adjust the vaccination by increasing the dose, the number of doses or the interval between them; the other is to mix vaccines with different technologies.
On this point, he commented on the following: “In this regard, I suggest that we consider adjusting the vaccination process and the number of doses and intervals, and use sequential vaccination with different types of antigens.”.
So far, China has approved four COVID vaccines for emergency use: two vaccines developed by Sinopharm Pharmaceutical Holdings, one produced by Sinovac, and one produced by CanSino.. It should be noted that Asian countries have also sent millions of doses to countries in Asia, Africa and Latin America.
*Information from country